Get the Stockscreener App
8.20
4.86%
0.38
After Hours:
8.21
0.01
+0.12%
Fennec Pharmaceuticals Inc stock is traded at $8.20, with a volume of 148.95K.
It is up +4.86% in the last 24 hours and up +7.61% over the past month.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
See More
Previous Close:
$7.82
Open:
$7.94
24h Volume:
148.95K
Relative Volume:
0.94
Market Cap:
$280.06M
Revenue:
$21.25M
Net Income/Loss:
$-16.05M
P/E Ratio:
-13.44
EPS:
-0.61
Net Cash Flow:
$-17.14M
1W Performance:
+7.05%
1M Performance:
+7.61%
6M Performance:
-11.26%
1Y Performance:
+25.77%
1-Day Range:
$7.94
$8.66
1-Week Range:
$7.55
$8.66
52-Week Range:
$4.68
$9.92
Fennec Pharmaceuticals Inc Stock (FENC) Company Profile
Name
Fennec Pharmaceuticals Inc
Sector
Industry
Phone
(919) 636-4530
Address
PO BOX 13628, RESEARCH TRIANGLE PARK, NC
Compare FENC vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
FENC
Fennec Pharmaceuticals Inc
|
8.20 | 267.08M | 21.25M | -16.05M | -17.14M | -0.61 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.02 | 117.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
783.65 | 82.35B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
833.54 | 51.64B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
308.48 | 42.58B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.42 | 38.87B | 4.98B | 69.60M | 525.67M | 0.5198 |
Fennec Pharmaceuticals Inc Stock (FENC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-09-26 | Initiated | Piper Sandler | Overweight |
| Nov-22-22 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Sep-07-22 | Initiated | CapitalOne | Overweight |
| Aug-08-22 | Resumed | Craig Hallum | Buy |
| Jun-05-20 | Initiated | Cantor Fitzgerald | Overweight |
| Oct-11-18 | Initiated | Goldman | Buy |
View All
Fennec Pharmaceuticals Inc Stock (FENC) Latest News
B. Riley Initiates Fennec Pharmaceuticals at Buy With CA$21.69 Price Target - marketscreener.com
B.Riley initiates Fennec Pharmaceuticals stock with Buy rating, $16 target By Investing.com - Investing.com India
B.Riley initiates Fennec Pharmaceuticals stock with Buy rating, $16 target - Investing.com
Fennec Pharmaceuticals (TSE:FRX) Stock Passes Below Fifty Day Moving AverageHere's What Happened - MarketBeat
How To Trade (FRX) (FRX:CA) - Stock Traders Daily
Why Fennec Pharmaceuticals Inc. stock is recommended by analystsTrade Volume Report & Pattern Based Trade Signal System - mfd.ru
Adherex Technologies Inc. (NASDAQ:FENC) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Avoiding Lag: Real-Time Signals in (FENC) Movement - Stock Traders Daily
(FRX) Market Dynamics and Trading Signals (FRX:CA) - Stock Traders Daily
Panic Selling: Is Fennec Pharmaceuticals Inc stock influenced by commodity prices2025 Volatility Report & Daily Entry Point Trade Alerts - baoquankhu1.vn
Risk Off: Does Fennec Pharmaceuticals Inc outperform in volatile markets2025 Investor Takeaways & Weekly Watchlist for Consistent Profits - baoquankhu1.vn
Insider Buy: Will Fennec Pharmaceuticals Inc benefit from AI trendsPortfolio Gains Summary & Risk Adjusted Swing Trade Ideas - baoquankhu1.vn
Investment Recap: Will Fennec Pharmaceuticals Inc benefit from AI trendsTrade Volume Summary & Safe Capital Growth Stock Tips - baoquankhu1.vn
Fennec Pharmaceuticals (TSE:FRX) Stock Crosses Below Fifty Day Moving AverageHere's What Happened - MarketBeat
Southpoint trims stake in Fennec Pharmaceuticals to 8% - MSN
Insider Selling: Adherex Technologies (NASDAQ:FENC) Director Sells 10,349 Shares of Stock - MarketBeat
Update Report: Can Fennec Pharmaceuticals Inc expand its profit marginsMarket Performance Recap & Scalable Portfolio Growth Ideas - baoquankhu1.vn
Aug EndMonth: What is Fennec Pharmaceuticals Incs valuation compared to sectorInflation Watch & Daily Stock Trend Watchlist - baoquankhu1.vn
How the (FRX) price action is used to our Advantage (FRX:CA) - Stock Traders Daily
Discipline and Rules-Based Execution in FENC Response - Stock Traders Daily
(FRX) Strategic Equity Report (FRX:CA) - Stock Traders Daily
Southpoint Capital Advisors Lp Sells 1,000,000 Shares of Fennec Pharmaceuticals (TSE:FRX) Stock - Defense World
Analyst Upgrade: Is Oculis Holding AG Equity Warrant forming higher highs and higher lowsTrade Entry Summary & Fast Momentum Entry Tips - baoquankhu1.vn
CEO Change: Why is Fennec Pharmaceuticals Inc stock going downJuly 2025 Snapshot & AI Driven Price Predictions - baoquankhu1.vn
Fennec Pharmaceuticals (TSE:FRX) Insider Sells C$10,350,000.00 in Stock - MarketBeat
(FRX) Financial Trading Report (FRX:CA) - Stock Traders Daily
Fennec Pharmaceuticals (TSE:FRX) Share Price Passes Above 50-Day Moving AverageWhat's Next? - MarketBeat
Trading (FRX) With Integrated Risk Controls (FRX:CA) - Stock Traders Daily
Does Fennec Pharmaceuticals Inc. have a sustainable dividendNew Guidance & Free Growth Oriented Trading Recommendations - bollywoodhelpline.com
(FRX) Daily Stock Insights (FRX:CA) - Stock Traders Daily
Behavioral Patterns of FENC and Institutional Flows - Stock Traders Daily
Wall Street Zen Downgrades Adherex Technologies (NASDAQ:FENC) to Buy - MarketBeat
Buyback Watch: What is the long term forecast for Fennec Pharmaceuticals Inc stockJuly 2025 Fed Impact & Low Risk Entry Point Guides - baoquankhu1.vn
Adherex Technologies Inc. (NASDAQ:FENC) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Adherex Technologies Inc. (NASDAQ:FENC) Receives Average Rating of “Moderate Buy” from Brokerages - Defense World
(FRX) Market Insights and Trading Signals (FRX:CA) - Stock Traders Daily
Fennec Pharmaceuticals (TSE:FRX) Share Price Passes Below Fifty Day Moving AverageHere's What Happened - MarketBeat
Fennec Pharmaceuticals (TSX:FRX) Price Target Increased by 10.41% to 21.57 - Nasdaq
(FRX) Strategic Investment Report (FRX:CA) - Stock Traders Daily
Adherex Technologies (NASDAQ:FENC) Now Covered by Piper Sandler - Defense World
How Fennec Pharmaceuticals Inc. stock reacts to bond yieldsJuly 2025 Spike Watch & Smart Investment Allocation Insights - Улправда
Piper Sandler initiates Fennec Pharmaceuticals stock with Overweight rating By Investing.com - Investing.com Nigeria
Piper Sandler initiates Fennec Pharmaceuticals stock with Overweight rating - Investing.com India
Can Fennec Pharmaceuticals Inc. (RV41) stock stage a strong rebound this quarterJuly 2025 Fed Impact & AI Forecast for Swing Trade Picks - Улправда
Is Fennec Pharmaceuticals Inc. (RV41) stock attractive for growth fundsEarnings Miss & Safe Entry Point Identification - Улправда
Is Fennec Pharmaceuticals Inc. (RV41) stock a safe buy pre earningsJuly 2025 Patterns & Stepwise Entry and Exit Trade Signals - Улправда
Published on: 2026-01-08 23:30:09 - Улправда
Can Fennec Pharmaceuticals Inc. stock continue upward trendJuly 2025 Update & Weekly High Momentum Picks - Улправда
(FRX) Investment Performance Report (FRX:CA) - Stock Traders Daily
Fennec Pharmaceuticals Inc Stock (FENC) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.24%
0.19%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):